{"id":1210,"date":"2020-03-25T15:24:44","date_gmt":"2020-03-25T14:24:44","guid":{"rendered":"https:\/\/leo-foundation.org\/da\/?p=1210"},"modified":"2020-09-30T15:44:56","modified_gmt":"2020-09-30T13:44:56","slug":"leo-fondets-aarsrapport-2019","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/da\/2020\/03\/25\/leo-fondets-aarsrapport-2019\/","title":{"rendered":"LEO Fondets \u00c5rsrapport 2019"},"content":{"rendered":"\n
<\/div>\n\n\n\n

H\u00f8jt afkast p\u00e5 DKK 2,3 milliarder p\u00e5 LEO Fondets investeringer og en betydelig fremgang i LEO Pharmas transition mod innovative behandlinger af hudsygdomme.<\/strong><\/p>\n\n\n\n

Hovedpunkterne i \u00e5rsregnskabet er:<\/p>\n\n\n\n

LEO Pharma<\/strong><\/p>\n\n\n\n